Navigation Links
Renhuang Reports Record Fiscal 2009 Results; Resumes Compliance With SEC Filing Requirements
Date:2/8/2010

HARBIN, China, Feb. 8 /PRNewswire-Asia-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheet: RHGP) ("Renhuang" or the "Company"), a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines ("TCM"), announced today that it has filed its annual report on Form 10-K for the fiscal year ended October 31, 2009 on time. In addition, the Company has filed all required quarterly and annual reports and is in compliance again with SEC filing requirements. Renhuang is committed to maintaining its current filer status and to providing investor transparency. The Company expects to report financial results for the first quarter ended January 31, 2010 on or before the filing deadline of March 17.

Renhuang filed its annual report on Form 10-K for the fiscal year ended October 31, 2009 on January 29, 2010. For the full fiscal year 2009, net sales were a record $43.4 million, as compared to $34.5 million for fiscal year 2008. Net income for 2009 was a record $14.8 million, or $0.41 per diluted share, as compared to net income of $10.3 million, or $0.29 per diluted share, for the same period in 2008.

"Regaining our ability to fulfill our filing requirements was an important milestone for Renhuang and demonstrated the Company's commitment to improving our corporate governance," said Mr. Shaoming Li, Renhuang's Chairman and CEO. "I am very proud of our record performance in fiscal 2009 while building momentum for fiscal 2010 an
'/>"/>

SOURCE Renhuang Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Renhuang Pharmaceuticals, Inc. Retains CCG Elite
2. Renhuang Pharmaceuticals, Inc. Holds Trade Show for Tianma Pills; Signs Letters of Intent
3. Renhuang Pharmaceuticals, Inc. Engages New Independent Auditor
4. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
5. Haemacure Reports Third Quarter 2007 Results
6. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
7. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
8. MDS Reports Third Quarter 2007 Results
9. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
10. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
11. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Exposed Skin Care has finally been released after ... all ages finally achieve the clear, beautiful skin they have ... acne clearing system combines the power of science and nature ... forming. , After a quick review of ... of the most effective available on the market to cure ...
(Date:6/18/2013)... An apple a day might really keep the ... breast cancer, she chose a different method for beating ... Cancer, I Can Take It Away!: Alternatives Brought Me ... how changing her physical, mental and emotional diet cured ... to feel fearful when diagnosed with a disease of ...
(Date:6/18/2013)... As obesity rates sky rocket in the ... equipment during childbirth comes as no shock. Forceps are surgical ... when she is unable to do so herself and although ... higher rates of complication for both the mother and the ... mother and child, forceps births add to the pressure of ...
(Date:6/18/2013)... 2013 Parker Waichman LLP , ... of victims injured by defective medical devices, reports that ... Infuse bone graft products are now available. Published this ... the two studies serve up two key findings: There ... Infuse and the traditional bone graft; and there is ...
(Date:6/18/2013)... Biomet hip lawsuit claims involving ... a multidistrict litigation in U.S. District Court, Northern District ... court records, the litigation’s most recent status conference was ... also convened a motions hearing and a tutorial on ... hip replacement litigation. The proceeding’s next Status Conference ...
Breaking Medicine News(10 mins):Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 3Health News:Cancer Survivor Linda Christina Beauregard Writes New Tell-All Book About Her Alternative Treatment Method 2Health News:Forceps Births Double, Obesity is Major Reason in Births Complications 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 2Health News:Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments 3Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 2Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 3
... In cancer research, as in most other biomedical sciences, ... in sterile plastic containers with red culture media populating ... always know what is really living in their culture ... impossible to distinguish from each other. When these important ...
... have a higher incidence of insufficient amniotic fluid levels ... a study conducted by researchers at Ben-Gurion University of the ... the July issue of Archives of Gynecology and Obstetrics ... determine whether the summer season is a risk factor for ...
... monkey experiment finds , THURSDAY, July 30 (HealthDay News) ... their mistakes, but new research sugests people may figure ... , In experiments with monkeys, researchers at the Picower ... Technology (MIT) found that only correct actions resulted in ...
... - rL Solutions, the leading provider of healthcare quality ... sponsoring the 2009 MITSS HOPE Award. MITSS and rL ... Annual Dinner and Fundraiser on Thursday, November 12, 2009, ... established this award in 2008 to recognize people who ...
... , BURBANK, Calif., July 30 ... UVC devices for HVAC systems, reports that the new Muskogee Community ... innovative infection control strategy. , , The ... ceiling-mounted devices in the surgical and procedural suites, marking the first ...
... , NEW YORK, July 30 ... their "Less Is More" campaign, which will encourage participants to bring ... others through simple, every day thoughtful actions. The campaign will be ... on September 26, 2009 with the help of the online party ...
Cached Medicine News:Health News:New test for safer biomedical research results 2Health News:Summer heat increases risk of amniotic fluid level deficiency, Ben-Gurion University study reveals 2Health News:Learning Takes Place When You Get Things Right 2Health News:rL Solutions to Sponsor 2009 MITSS HOPE Award 2Health News:Muskogee Community Hospital Adopts Steril-Aire UVC Lights for Infection Control, Green Benefits 2Health News:Muskogee Community Hospital Adopts Steril-Aire UVC Lights for Infection Control, Green Benefits 3Health News:Metabolife(R) Reminds Us That the Little Things We Do Can Bring Positive Change to Our Lives and the Lives of Others 2
(Date:6/18/2013)... , Safinamide significantly improves ... as add-on to levodopa Safinamide is ... in fluctuating PD patients as add-on to levodopa ... ("Newron"), a research and development company focused on ... Zambon S.p.A., a pharmaceutical company strongly committed to ...
(Date:6/18/2013)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... VPII Escrow Corp., a newly formed wholly owned Canadian ... approximately $3.2 billion aggregate principal amount of senior unsecured ... 2021 and in 2023, with final tranching determined at ... net proceeds from the offering, together with proceeds from ...
(Date:6/18/2013)... 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT ... development and commercialization of novel bile acid therapeutics to ... an underwritten public offering of 1,730,000 shares of its ... per share.  In addition, Intercept has granted the underwriters ... 259,500 shares of common stock. All of ...
Breaking Medicine Technology:Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 2Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 3Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
... UL, a world leader in advancing ... testing GmbH (MDT) and md registration support Ltd. (MDRS).  These ... UL,s Life and Health business unit.   MDT ... the medical services industry.  MDT specializes in clinical and non-clinical ...
... 2011 Apnex Medical, Inc., received investigational device exemption ... (FDA) to begin a clinical study to evaluate the ... System to treat obstructive sleep apnea (OSA). Data from ... Approval (PMA) application for the HGNS System to the ...
Cached Medicine Technology:UL Expands Presence in Medical Device Market With Acquisition of MDT 2UL Expands Presence in Medical Device Market With Acquisition of MDT 3Apnex Medical, Inc. Receives FDA Approval for Pivotal Clinical Study for Obstructive Sleep Apnea 2Apnex Medical, Inc. Receives FDA Approval for Pivotal Clinical Study for Obstructive Sleep Apnea 3
Directional `E' and `C' test....
9" X 14" translucent plastic may be used with illuminated test cabinet or as a wall chart 20/200 to 20/15....
... The PowerLab/16SP is a high-performance recording unit ... science research applications that require up to ... and isolated tissue studies. The unit is ... to 200 000 samples per second continuously ...
Three Figure Worth Type Test, this test is used for determining diplopia, suppression or fusion in children. Sturdy chrome flashlight comes with red/green glasses. Requires 3 D batteries which are no...
Medicine Products: